SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-17-279702
Filing Date
2017-09-08
Accepted
2017-09-08 06:06:04
Documents
1
Group Members
ADAM GRAYCHRISTOPHER SHACKELTONCOLISEUM CAPITAL PARTNERS II, L.P.COLISEUM CAPITAL PARTNERS, L.P.COLISEUM CAPITAL, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d450592dsc13da.htm SC 13D/A 111157
  Complete submission text file 0001193125-17-279702.txt   112851
Mailing Address 1600 BROADWAY SUITE 950 DENVER CO 80202
Business Address 1600 BROADWAY SUITE 950 DENVER CO 80202 720 697 5200
BioScrip, Inc. (Subject) CIK: 0001014739 (see all company filings)

IRS No.: 050489664 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-49459 | Film No.: 171075051
SIC: 8082 Services-Home Health Care Services

Mailing Address 105 ROWAYTON AVENUE ROWAYTON CT 06853
Business Address 105 ROWAYTON AVENUE ROWAYTON CT 06853 203-883-0100
Coliseum Capital Management, LLC (Filed by) CIK: 0001409751 (see all company filings)

IRS No.: 223918079
Type: SC 13D/A